TRIAL DETAIL
Phase 1 Study of Oral KOS-1022 in Patients with Advanced Solid Tumors
Drug: |
||||
|---|---|---|---|---|
Trial Name: |
Phase 1 Study of Oral KOS-1022 in Patients with Advanced Solid Tumors |
|||
NCT#: |
||||
Conditions: |
Advanced Solid Tumors |
|||
Status: |
Withdrawn |
|||
Phase: |
1 |
Start Date |
Age of Trial (yrs) |
|
Treatment Phase: |
Gleevec-resistant |
|||
Drug Category: |
HSP90 inhibitor |
|||
Strategy: |
Destroy KIT |
|||
Trial Type: |
GIST not specified. GIST patient enrollment unknown. |
|||
Other Protocol IDs: |
COMIRB 05-0627,
PRMC 05-87 |
|||
Sponsor: |
Kosan |
|||
Patient Contact: |
Sarah Eppers |
|||
Contact email: |
sarah.eppers@uchsc.edu |
|||
Contact Phone: |
720-848-0052 |
|||
Randomized: |
||||
IV or Oral: |
Oral |
|||
Trial Notes: |
KOS-1022 is an oral HSP-90 inhibitor. This trial is still listed as open in Univ Colo.site. However, the drug is no longer listed in the Kosan pipeline.Last time I talked to Sarah Eppers the company was backing away from this drug. Link to Univ. of CO listing is no longer working 1/26/09. |
|||
Trial Links |
Trial Results |
Drug Information |
Trial Sites
Name |
Address |
City |
State |
Zip |
Country |
1665 N. Ursula St. |
Aurora |
CO |
80045 |
USA |